Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro

Non-alcoholic fatty liver disease (NAFLD) causes liver dysfunction and is associated with obesity and type 2 diabetes. Chronic inflammation is associated not only with the development of NAFLD, but also with hepatic diseases, including steatohepatitis, cirrhosis, and hepatocellular carcinoma. Aurano...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwangbo, Hyun, Kim, Min Yeong, Ji, Seon Yeong, Kim, So Young, Lee, Hyesook, Kim, Gi-Young, Park, Cheol, Keum, Young-Sam, Hong, Su Hyun, Cheong, Jaehun, Choi, Yung Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690872/
https://www.ncbi.nlm.nih.gov/pubmed/33114221
http://dx.doi.org/10.3390/antiox9111040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690872/
https://www.ncbi.nlm.nih.gov/pubmed/33114221
http://dx.doi.org/10.3390/antiox9111040

Ejemplares similares